198 related articles for article (PubMed ID: 19835057)
41. The lymphocyte transformation test in the diagnosis of drug hypersensitivity.
Pichler WJ; Tilch J
Allergy; 2004 Aug; 59(8):809-20. PubMed ID: 15230812
[TBL] [Abstract][Full Text] [Related]
42. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.
Beeler A; Engler O; Gerber BO; Pichler WJ
J Allergy Clin Immunol; 2006 Feb; 117(2):455-62. PubMed ID: 16461148
[TBL] [Abstract][Full Text] [Related]
43. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors.
Abbas AK; Haber S; Rock KL
J Immunol; 1985 Sep; 135(3):1661-7. PubMed ID: 2410498
[TBL] [Abstract][Full Text] [Related]
44. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
[TBL] [Abstract][Full Text] [Related]
45. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
[TBL] [Abstract][Full Text] [Related]
46. Reactive metabolites and their role in drug reactions.
Naisbitt DJ; Williams DP; Pirmohamed M; Kitteringham NR; Park BK
Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):317-25. PubMed ID: 11964707
[TBL] [Abstract][Full Text] [Related]
47. Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.
Elsheikh A; Castrejon L; Lavergne SN; Whitaker P; Monshi M; Callan H; El-Ghaiesh S; Farrell J; Pichler WJ; Peckham D; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2011 Jun; 127(6):1543-51.e3. PubMed ID: 21354601
[TBL] [Abstract][Full Text] [Related]
48. In vitro tests in drug hypersensitivity diagnosis.
Lochmatter P; Zawodniak A; Pichler WJ
Immunol Allergy Clin North Am; 2009 Aug; 29(3):537-54. PubMed ID: 19563996
[TBL] [Abstract][Full Text] [Related]
49. In vitro diagnosis of T cell-mediated drug allergy.
Porebski G; Gschwend-Zawodniak A; Pichler WJ
Clin Exp Allergy; 2011 Apr; 41(4):461-70. PubMed ID: 21338430
[TBL] [Abstract][Full Text] [Related]
50. [The participation of the T system and macrophages in the immediate immune response to drug compounds].
Zaks AS; Bykova AA; Iushkova TA
Eksp Klin Farmakol; 1995; 58(3):45-7. PubMed ID: 7663297
[TBL] [Abstract][Full Text] [Related]
51. T cell-dependent mediator in the immune response. III. The role of non-specific factor (NSF) in the in vitro immune response.
Waldmann H
Immunology; 1975 Mar; 28(3):497-507. PubMed ID: 1092612
[TBL] [Abstract][Full Text] [Related]
52. T cells reactive to keratinocyte antigens are generated during induction of contact hypersensitivity in mice. A model for autoeczematization in humans?
Fehr BS; Takashima A; Bergstresser PR; Cruz PD
Am J Contact Dermat; 2000 Sep; 11(3):145-54. PubMed ID: 11012002
[TBL] [Abstract][Full Text] [Related]
53. An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.
Chen CB; Abe R; Pan RY; Wang CW; Hung SI; Tsai YG; Chung WH
J Immunol Res; 2018; 2018():6431694. PubMed ID: 29651444
[TBL] [Abstract][Full Text] [Related]
54. Antigenicity and immune recognition.
Virella G
Immunol Ser; 1990; 50():53-76. PubMed ID: 2091768
[No Abstract] [Full Text] [Related]
55. The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity.
Lavergne SN; Park BK; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):299-307. PubMed ID: 18596585
[TBL] [Abstract][Full Text] [Related]
56. Mechanisms leading to T-cell activation in drug hypersensitivity.
Meng X; Yerly D; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):317-324. PubMed ID: 29905574
[TBL] [Abstract][Full Text] [Related]
57. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity.
Lochmatter P; Beeler A; Kawabata TT; Gerber BO; Pichler WJ
Allergy; 2009 Sep; 64(9):1269-78. PubMed ID: 19254289
[TBL] [Abstract][Full Text] [Related]
58. Clonal dominance and the preservation of clonal memory cells mediated by antigen-antibody.
Askonas BA; McMichael AJ; Roux ME
Immunology; 1976 Oct; 31(4):541-51. PubMed ID: 1086284
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the T-cell response in a patient with phenindione hypersensitivity.
Naisbitt DJ; Farrell J; Chamberlain PJ; Hopkins JE; Berry NG; Pirmohamed M; Park BK
J Pharmacol Exp Ther; 2005 Jun; 313(3):1058-65. PubMed ID: 15743920
[TBL] [Abstract][Full Text] [Related]
60. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens.
Thierse HJ; Gamerdinger K; Junkes C; Guerreiro N; Weltzien HU
Toxicology; 2005 Apr; 209(2):101-7. PubMed ID: 15767020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
